Literature DB >> 10641596

Vascular smooth muscle differentiation of murine stroma: a sequential model.

J P Remy-Martin1, A Marandin, B Challier, G Bernard, M Deschaseaux, P Herve, Y Wei, T Tsuji, R Auerbach, J E Dennis, K A Moore, J S Greenberger, P Charbord.   

Abstract

Previous studies by our group showed that stromal cells from human long-term marrow cultures were mesenchymal cells following a vascular smooth muscle pathway. The present study using 58 immortalized stromal lines from different hematopoietic sites was conducted to verify whether this hypothesis also held true for murine stroma. Principal components analysis performed using cytoskeletal and extracellular matrix proteins allowed the segregation of five factors explaining more than 70% of the variance. Factor I, including osteopontin and vimentin, and factor II, laminins and fibronectins, were representative of the mesenchyme. The remaining three factors were representative of vascular smooth muscle: factor III, including alphaSM actin, SM alpha actinin, SM22alpha, EDa+ fibronectin, and thrombospondin-1; factor IV, metavinculin and h-caldesmon; and factor V, smooth muscle myosin SM1 and desmin. All lines expressed factors I and II; 53 lines expressed factor III, 35 lines expressed factor IV; and 11 lines expressed factor V. A second principal components analysis including membrane antigens indicated the cosegregration of vascular cell adhesion molecule-1 with osteopontin and that of Ly6A/E with vimentin, whereas CD34 and Thy-1 appeared to be independent factors. The heterogeneity of vascular smooth muscle markers expression suggests that harmonious maintenance of hematopoiesis depends on the cooperation between different stromal cell clones.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10641596     DOI: 10.1016/s0301-472x(99)00122-8

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  7 in total

Review 1.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

2.  Expression of Pitx2 in stromal cells is required for normal hematopoiesis.

Authors:  Aurélie Kieusseian; Jalila Chagraoui; Cécile Kerdudo; Philippe-Emmanuel Mangeot; Philip J Gage; Nicole Navarro; Brigitte Izac; Georges Uzan; Bernard G Forget; Anne Dubart-Kupperschmitt
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

Review 3.  Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation.

Authors:  Charalampos Pontikoglou; Frédéric Deschaseaux; Luc Sensebé; Helen A Papadaki
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

4.  Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells.

Authors:  Larissa V Rodríguez; Zeni Alfonso; Rong Zhang; Joanne Leung; Benjamin Wu; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

5.  Oncostatin m regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines.

Authors:  N Yanai; M Obinata
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

6.  Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model.

Authors:  Ana Paula D N de Barros; Christina M Takiya; Luciana R Garzoni; Mona Lisa Leal-Ferreira; Hélio S Dutra; Luciana B Chiarini; Maria Nazareth Meirelles; Radovan Borojevic; Maria Isabel D Rossi
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 7.  Novel immune signals and atherosclerosis.

Authors:  Hiroshi Iwata; Ryozo Nagai
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.